Arrowhead Pharmaceuticals, Inc. - stock earnings
ARWR Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -132.9 million USD | 3.6 million USD |
| 2023Q3 | -109.7 million USD | 16.1 million USD |
| 2023Q2 | -102.9 million USD | 15.8 million USD |
| 2023Q1 | 48.7 million USD | 146.3 million USD |
| 2022Q4 | -41.8 million USD | 62.5 million USD |
| 2022Q3 | -85.9 million USD | 31.6 million USD |
| 2022Q2 | -71.2 million USD | 32.4 million USD |
| 2022Q1 | 44.4 million USD | 151.8 million USD |
| 2021Q4 | -62.9 million USD | 27.4 million USD |
| 2021Q3 | -63.4 million USD | 38.3 million USD |
| 2021Q2 | -29.9 million USD | 45.9 million USD |
| 2021Q1 | -26.8 million USD | 32.8 million USD |
| 2020Q4 | -20.7 million USD | 21.3 million USD |
| 2020Q3 | -48.4 million USD | 7.6 million USD |
| 2020Q2 | -13.6 million USD | 27.4 million USD |
| 2020Q1 | -19.8 million USD | 23.5 million USD |
| 2019Q4 | -2.7 million USD | 29.5 million USD |
| 2019Q3 | 11.7 million USD | 43.3 million USD |
| 2019Q2 | 20.3 million USD | 42.7 million USD |
| 2019Q1 | 23.9 million USD | 48.1 million USD |
| 2018Q4 | 12.0 million USD | 34.7 million USD |
| 2018Q3 | -10.8 million USD | 11.3 million USD |
| 2018Q2 | -15.6 million USD | 727375 USD |
| 2018Q1 | -14.9 million USD | 650125 USD |
| 2017Q4 | -13.2 million USD | 3.5 million USD |
| 2017Q3 | -10.7 million USD | 8.7 million USD |
| 2017Q2 | -5.5 million USD | 9.3 million USD |
| 2017Q1 | -6.0 million USD | 9.0 million USD |
| 2016Q4 | -12.1 million USD | 4.4 million USD |
| 2016Q3 | -22.2 million USD | 31250 USD |
| 2016Q2 | -19.4 million USD | 39583 USD |
| 2016Q1 | -20.8 million USD | 43750 USD |
| 2015Q4 | -19.3 million USD | 43750 USD |
| 2015Q3 | -24.7 million USD | 43750 USD |
| 2015Q2 | -15.9 million USD | 123750 USD |
| 2015Q1 | -28.7 million USD | 43750 USD |
| 2014Q4 | -22.6 million USD | 170750 USD |
| 2014Q3 | -22.4 million USD | 43750 USD |
| 2014Q2 | -11.6 million USD | 43750 USD |
| 2014Q1 | -13.9 million USD | 43750 USD |
| 2013Q4 | -10.6 million USD | 43750 USD |
| 2013Q3 | -13.7 million USD | 43750 USD |
| 2013Q2 | -6.1 million USD | 43750 USD |
| 2013Q1 | -6.8 million USD | 43750 USD |
| 2012Q4 | -4.6 million USD | 159016 USD |
| 2012Q3 | -5.3 million USD | 43750 USD |
| 2012Q2 | -8.0 million USD | 47917 USD |
| 2012Q1 | -5.3 million USD | 31250 USD |
| 2011Q4 | -2.5 million USD | 23958 USD |
| 2011Q3 | -2.8 million USD | 290.8 million USD |
| 2011Q2 | -1.8 million USD | ? USD |
| 2011Q1 | 2.9 million USD | 296139 USD |
| 2010Q4 | -1.4 million USD | 5.0 million USD |
| 2010Q3 | -2.0 million USD | 180694 USD |
| 2010Q2 | -371055 USD | 133990 USD |
| 2010Q1 | -1.9 million USD | 157346 USD |
| 2009Q4 | -1.5 million USD | 148068 USD |
| 2009Q3 | -3.5 million USD | 202583 USD |
| 2009Q2 | -2.5 million USD | 2.6 million USD |
| 2009Q1 | -5.3 million USD | 235650 USD |
| 2008Q4 | -8.0 million USD | 701723 USD |
| 2008Q3 | -8.7 million USD | -59798 USD |
| 2008Q2 | -7.5 million USD | 235372 USD |
| 2008Q1 | -5.7 million USD | 729766 USD |
| 2007Q4 | -5.2 million USD | 402861 USD |
| 2007Q3 | -7.6 million USD | 578028 USD |
| 2007Q2 | -12.5 million USD | 622599 USD |
| 2007Q1 | -6.2 million USD | 11000 USD |
| 2006Q4 | -3.7 million USD | 11092 USD |
| 2006Q3 | -8.8 million USD | 39229 USD |
| 2006Q2 | -4.0 million USD | 246229 USD |
| 2006Q1 | -3.1 million USD | 57500 USD |
| 2005Q4 | -3.1 million USD | 252500 USD |
| 2005Q3 | -2.7 million USD | 210275 USD |
| 2005Q2 | -3.0 million USD | 173304 USD |
| 2005Q1 | 642761 USD | 77614 USD |
| 2004Q4 | -1.5 million USD | 129490 USD |
| 2004Q3 | -1.5 million USD | 159106 USD |
| 2004Q2 | -638189 USD | 37200 USD |
| 2004Q1 | 30049 USD | ? USD |
| 2003Q4 | 108133 USD | -2651 USD |
| 2003Q3 | 108133 USD | ? USD |
| 2003Q2 | -53510 USD | 207 USD |
| 2003Q1 | -104763 USD | 875 USD |
| 2002Q4 | -84721 USD | 89 USD |
| 2002Q3 | -84721 USD | 89 USD |
| 2002Q2 | -88083 USD | 270 USD |
| 2002Q1 | -10153 USD | 555 USD |
| 2001Q4 | -63250 USD | 1352 USD |
| 2001Q3 | -60946 USD | 720 USD |
| 2001Q2 | -32648 USD | 3297 USD |
| 2001Q1 | -51389 USD | 95 USD |
| 2000Q4 | -40838 USD | 5200 USD |
| 2000Q3 | 34803 USD | 8436 USD |
| 2000Q2 | -57551 USD | 4827 USD |
| 2000Q1 | -54092 USD | 6600 USD |
| 1999Q4 | -50000 USD | 10000 USD |
| 1999Q3 | -50000 USD | 10000 USD |
| 1999Q2 | 680000 USD | 10000 USD |
| 1999Q1 | -20000 USD | 10000 USD |
| 1998Q4 | -20000 USD | 10000 USD |
| 1998Q3 | -20000 USD | 10000 USD |
| 1998Q2 | ? USD | 10000 USD |
| 1998Q1 | -10000 USD | 30000 USD |
ARWR Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -205.3 million USD | 240.7 million USD |
| 2022 | -176.5 million USD | 243.2 million USD |
| 2021 | -140.8 million USD | 138.3 million USD |
| 2020 | -84.6 million USD | 88.0 million USD |
| 2019 | 68.0 million USD | 168.8 million USD |
| 2018 | -54.5 million USD | 16.1 million USD |
| 2017 | -34.4 million USD | 31.4 million USD |
| 2016 | -81.7 million USD | 158333 USD |
| 2015 | -91.9 million USD | 382000 USD |
| 2014 | -58.6 million USD | 175000 USD |
| 2013 | -31.1 million USD | 290266 USD |
| 2012 | -21.1 million USD | 146875 USD |
| 2011 | -3.1 million USD | 296139 USD |
| 2010 | -5.8 million USD | 620097 USD |
| 2009 | -19.3 million USD | 3.8 million USD |
| 2008 | -27.1 million USD | 1.3 million USD |
| 2007 | -29.9 million USD | 1.2 million USD |
| 2006 | -19.0 million USD | 595458 USD |
| 2005 | -6.6 million USD | 590683 USD |
| 2004 | -2.5 million USD | 196306 USD |
| 2003 | -95238 USD | ? USD |
| 2002 | -246207 USD | 2266 USD |
| 2001 | -185821 USD | 9312 USD |
| 2000 | -137553 USD | 24878 USD |
| 1999 | 593003 USD | 36998 USD |
| 1998 | -51620 USD | 60378 USD |
| 1997 | -854535 USD | 76590 USD |
ARWR
Price: $22.48
52 week price:
Payout Ratio Range:
Earnings Per Share: -2.77 USD
P/E Ratio: -16.48
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 594870
Ebitda: -12.7 millionMarket Capitalization: 3.2 billion